$AKTX

$8.54▲ -0.1% YTD

6 SEC 13D/G filings tracked · Last updated Oct 13, 2026

Filing History

CP $8.54▲ -0.1%Oct 13, 2026 · ThinkSabio Blog

$AKTX - Akari Therapeutics Appoints Accomplished Oncology and ADC Deal Executive Vatnak Vat-Ho as Chief Business Officer to Drive Strategic Growth and…

News

AKTX ▲ +0.8% - Akari Therapeutics, Plc

CP $9.30▲ +0.8%Oct 1, 2026 · ThinkSabio Blog

$AKTX - Akari Therapeutics Expands Intellectual Property Portfolio with PCT Filing for ADC Payload Related to RNA Splicing in Cancers…

News

AKTX ▲ +3.3% - Akari Therapeutics, Plc

CP 9.40▲ +3.3%Aug 27, 2026 · ThinkSabio Blog

$AKTX - Akari Therapeutics Participates in the Virtual Investor "Why Now" On-Demand Conference…

SEC 13D/G

AKTX - Akari Therapeutics, Plc - SEC Filing Update (12-AUG-2026) | ThinkSabio - Stocks Simplified

$7.30▼ -37.07%Aug 12, 2026 · ThinkSabio Blog

$AKTX SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #AKTX Akari Therapeutics, Plc : $7.30 Sector: Healthcare | YTD:…

SEC 13D/G

AKTX - Akari Therapeutics, Plc - SEC Filing Update (07-AUG-2026) | ThinkSabio - Stocks Simplified

$7.50▼ -35.34%Aug 7, 2026 · ThinkSabio Blog

$AKTX SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #AKTX Akari Therapeutics, Plc : $7.50 Sector: Healthcare | YTD:…

SEC 13D/G

#AKTX-SEC-Update-(08-JUN-2026)-ThinkSabio-Stocks Simplified)

$15.20▼ 31.03%Jun 9, 2026 · ThinkSabio Blog

SEC Filing Update: #AKTX : $15.20 Sector: Healthcare | YTD: 31.03 % The SEC disclosed Today (08-JUN-2026) that MMCAP INTERNATIONAL INC SPC has Newly b…